Some Facts About Pneumocystis jirovecii | ||
| Annals of the College of Medicine, Mosul | ||
| Article 13, Volume 44, Issue 2, December 2022, Pages 185-191 PDF (381.41 K) | ||
| Document Type: Review Paper | ||
| DOI: 10.33899/mmed.2022.135399.1162 | ||
| Authors | ||
| Zahraa S. Qasim1; Marwah Hashem Dawood* 2; Zahraa A. Hashim1 | ||
| 1Department of Clinical Laboratory Sciences, College of Pharmacy, University of Mosul, Mosul, Iraq | ||
| 2Department of Clinical Laboratory Sciences, College of Pharmacy, University of Mosul, Mosul, Iraq. | ||
| Abstract | ||
| ABSTRACT Pneumocystis Jirovecii is aunique yeast-like fungus (previouslynamed Pneumocystis carinii). It has been demonstrated as a predominant cause of intrapulmonary and rarely extra-pulmonary infection and a significant cause of morbidity and mortality in immunocompromised patients with and without AIDS. Pneumocystis jirovecii was classified previously as protozoan endoparasite, and then reclassified as a fungus, based on nucleic acid analysis and biochemical characteristics. No successful cultural method for the organism had beenpreceded yet. Direct microscopic identification of the organism in biopsies or inspired materials is the method of choice for diagnosing the organism. Advanced molecular techniques offer a high sensitivity and specificity in P. Jirovecii diagnosis. Sulfa-based medicines have been shown effectiveness in P. Jirovecii infections treatment. Aim of this review to provide an updated knowledge on the role of P. jirovecii as a human pathogen. | ||
| Keywords | ||
| Immunocompromised patients,,; ,،,؛pathogenic Fungi,,; ,،,؛Pneumocystis jirovecii. Trypanosoma spp | ||
|
Statistics Article View: 160 PDF Download: 165 |
||